Bicyclic ureas and thiadiazolidine-1, 1-dioxides as CETP inhibitors
Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, wherein X is —C(═O) or —S(O)2—, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis.
Merck Sharp & Dohme Corp.
A A A A C A C A A A
A61P A61K A61P A61K C07D A61K C07D A61K A61K A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Petr Pengcheng Patrick Jian Arto K.
Vachal Shao Liu Krikorian